Serum Institute of India to resume trial for Oxford's COVID-19 vaccine candidate after DCGI nod

The trials were halted after AstraZeneca, the pharma company responsible for the vaccine, paused its UK trials after one of the volunteers developed a 'serious ailment'

Press Trust of India September 12, 2020 22:53:53 IST
Serum Institute of India to resume trial for Oxford's COVID-19 vaccine candidate after DCGI nod

Representational image.

Serum Institute of India will resume clinical trials of AstraZeneca's COVID-19 vaccine candidate after getting the permission from the Drugs Controller General of India (DCGI), the Pune-based vaccine maker said on Saturday.

Pharma giant AstraZeneca on Saturday said that clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that the trials were safe.

"Once DCGI will give us the permission to restart the trials in India, we will resume the trials," Serum Institute of India (SII) said in a statement.

In a tweet, SII CEO Adar Poonawalla said: "As I'd mentioned earlier, we should not jump to conclusions until the trials are fully concluded. The recent chain of events is a clear example why we should not bias the process and should respect the process till the end. Good news, @UniofOxford."

The human trials resumed days after a pause had been announced in the trials after an adverse reaction in one of the participants.

Following the suspension, the DCGI directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the vaccine candidate.

AstraZeneca and the University of Oxford, as the trial sponsor, on Saturday said that they cannot disclose further medical information but confirmed that independent investigations concluded that the trials were safe to restart.

Updated Date:

also read

NBA: Brooklyn Nets say Kyrie Irving won't play or practice with team until he can do it full time
Sports

NBA: Brooklyn Nets say Kyrie Irving won't play or practice with team until he can do it full time

Without mentioning his vaccination status, general manager Sean Marks said Kyrie Irving has made a decision that keeps him from being able to perform with the team.

India logs 16,862 new COVID-19 cases, 379 deaths in past 24 hours; active infections lowest in 216 days
India

India logs 16,862 new COVID-19 cases, 379 deaths in past 24 hours; active infections lowest in 216 days

The national COVID-19 recovery rate is at 98.07 percent, the highest since March 2020, according to the health ministry

NBA: Kyrie Irving likely to join Nets practice with training centre not falling under New York's vaccination mandate
Sports

NBA: Kyrie Irving likely to join Nets practice with training centre not falling under New York's vaccination mandate

Irving still wouldn't be able to play in home games if he doesn't meet the vaccination requirement, but at least he can be with the Nets when they are practicing at home.